tetracycline

tetracycline is a broad-spectrum antibiotic used to treat various infections caused by bacteria, including pneumonia diagnosed by National Institutes of Health and tuberculosis treated at Johns Hopkins Hospital. It is commonly prescribed by doctors at Mayo Clinic and Cleveland Clinic to patients suffering from acne and inflammatory conditions, such as rheumatoid arthritis studied by University of California, Los Angeles. The discovery of tetracycline is attributed to the work of Selman Waksman and Albert Schatz at Rutgers University, who also developed streptomycin.

Introduction

tetracycline belongs to a class of antibiotics that inhibit protein synthesis in bacteria, similar to chloramphenicol and erythromycin used at Massachusetts General Hospital. It is effective against a wide range of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and Escherichia coli studied by Centers for Disease Control and Prevention. The use of tetracycline has been recommended by World Health Organization and American Medical Association for the treatment of various infections, including chlamydia and gonorrhea diagnosed at University of California, San Francisco. Tetracycline is also used in veterinary medicine to treat infections in animals at University of Wisconsin–Madison and Texas A&M University.

History

The discovery of tetracycline is a significant milestone in the history of antibiotics, marked by the work of Selman Waksman and Albert Schatz at Rutgers University in the 1940s. The first tetracycline antibiotic, chlortetracycline, was isolated from Streptomyces aureofaciens by Pfizer in 1948. Since then, several tetracycline derivatives have been developed, including oxytetracycline and doxycycline used at Harvard University and Stanford University. The development of tetracycline has been recognized by the awarding of the Nobel Prize in Physiology or Medicine to Selman Waksman in 1952, and the Lasker Award to Albert Schatz in 1952, presented by Lasker Foundation and University of Oxford.

Mechanism_of_action

tetracycline works by inhibiting protein synthesis in bacteria, similar to aminoglycosides and macrolides studied by University of Cambridge and University of Edinburgh. It binds to the 30S ribosomal subunit of bacteria, preventing the attachment of aminoacyl-tRNA to the ribosome and thereby inhibiting protein synthesis researched by National Science Foundation and European Molecular Biology Organization. This mechanism of action is similar to that of chloramphenicol and erythromycin used at University of Toronto and McGill University. The use of tetracycline has been shown to be effective against a wide range of bacteria, including Streptococcus pneumoniae and Haemophilus influenzae studied by Centers for Disease Control and Prevention and World Health Organization.

Medical_uses

tetracycline is used to treat various infections caused by bacteria, including pneumonia and tuberculosis diagnosed at Johns Hopkins Hospital and Massachusetts General Hospital. It is also used to treat acne and inflammatory conditions, such as rheumatoid arthritis studied by University of California, Los Angeles and University of California, San Francisco. The use of tetracycline has been recommended by American Academy of Dermatology and American College of Rheumatology for the treatment of acne and rheumatoid arthritis respectively. Tetracycline is also used in veterinary medicine to treat infections in animals at University of Wisconsin–Madison and Texas A&M University, and in agriculture to promote growth in livestock at United States Department of Agriculture and Food and Agriculture Organization.

Side_effects

The use of tetracycline can cause several side effects, including gastrointestinal disturbances, such as nausea and vomiting diagnosed at Cleveland Clinic and Mayo Clinic. It can also cause phototoxicity and hepatotoxicity researched by National Institutes of Health and European Medicines Agency. The use of tetracycline during pregnancy can cause tooth discoloration and inhibition of bone growth in the fetus studied by American College of Obstetricians and Gynecologists and Royal College of Obstetricians and Gynaecologists. The use of tetracycline has been associated with the development of antibiotic resistance in bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus researched by Centers for Disease Control and Prevention and World Health Organization.

Chemical_properties

tetracycline is a polyketide antibiotic that consists of a tetracyclic ring system, similar to erythromycin and chloramphenicol studied by University of Cambridge and University of Oxford. It is a yellow, crystalline powder that is soluble in water and ethanol researched by National Science Foundation and European Molecular Biology Organization. The chemical structure of tetracycline is composed of a naphthacene ring system, with a hydroxyl group and a methyl group attached to the ring. The use of tetracycline has been shown to be effective against a wide range of bacteria, including Streptococcus pneumoniae and Haemophilus influenzae studied by Centers for Disease Control and Prevention and World Health Organization. Category:Antibiotics